# SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia

> **NCT02769845** · NA · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 283 (actual)

## Conditions studied

- Sickle Cell Anemia

## Interventions

- **DRUG:** Hydroxyurea
- **PROCEDURE:** TCD examination

## Key facts

- **NCT ID:** NCT02769845
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-16
- **Primary completion:** 2019-07-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 283 (ACTUAL)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02769845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02769845, "SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02769845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*